+1,100.9%
MRNA vs GLDM
+208.8%
+892.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GLDM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.1% | -3.6% | -3.5% |
| 7D | -12.1% | -4.6% | -7.5% | -9.6% |
| 30D | -1.3% | -5.5% | +4.2% | +2.4% |
| 3M | +250.9% | -10.9% | +261.8% | +279.2% |
| 6M | +343.0% | -17.3% | +360.3% | +385.3% |
| YTD | +657.4% | -10.2% | +667.6% | +728.6% |
| 1Y | +794.9% | -6.9% | +801.9% | +875.5% |
| 3Y | +218.1% | +98.7% | +119.5% | +232.6% |
| 5Y | -3.4% | +106.7% | -110.1% | -1.1% |
| All | +1,100.9% | +208.8% | +892.1% | +1,343.1% |
Cumulative growth
Daily Returns
Daily percentage return beside GLDM.
Daily Out/Under-Performance
Portfolio return minus GLDM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GLDM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GLDM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling